DFA
REGN icon

Delta Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Delta Financial Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Sell
1,444
-9
-0.6% -$6.89K 0.29% 88
2025
Q4 		$1.12M Sell
1,453
-25
-2% -$17K 0.29% 87
2025
Q3 		$831K Buy
1,478
+41
+3% +$23.2K 0.23% 90
2025
Q2 		$755K Buy
1,437
+14
+1% +$7.81K 0.27% 80
2025
Q1 		$903K Buy
1,423
+70
+5% +$48.1K 0.34% 73
2024
Q4 		$964K Sell
1,353
-2
-0.1% -$1.68K 0.36% 70
2024
Q3 		$1.42M Sell
1,355
-40
-3% -$44.5K 0.52% 60
2024
Q2 		$1.47M Hold
1,395
– – 0.57% 57
2024
Q1 		$1.34M Buy
1,395
+15
+1% +$14.3K 0.53% 62
2023
Q4 		$1.21M Buy
1,380
+100
+8% +$82.3K 0.53% 61
2023
Q3 		$1.05M Hold
1,280
– – 0.47% 66
2023
Q2 		$920K Sell
1,280
-35
-3% -$27K 0.41% 74
2023
Q1 		$1.08M Sell
1,315
-40
-3% -$30.2K 0.52% 63
2022
Q4 		$978K Hold
1,355
– – 0.47% 66
2022
Q3 		$933K Sell
1,355
-5
-0.4% -$3.15K 0.5% 66
2022
Q2 		$804K Hold
1,360
– – 0.4% 80
2022
Q1 		$950K Buy
1,360
+5
+0.4% +$3.16K 0.41% 74
2021
Q4 		$856K Buy
1,355
+5
+0.4% +$3.07K 0.35% 79
2021
Q3 		$817K Sell
1,350
-10
-0.7% -$6.21K 0.36% 80
2021
Q2 		$760K Buy
1,360
+81
+6% +$41K 0.33% 82
2021
Q1 		$605K Buy
1,279
+86
+7% +$41.9K 0.28% 87
2020
Q4 		$576K Buy
1,193
+105
+10% +$56.7K 0.29% 86
2020
Q3 		$609K Buy
1,088
+35
+3% +$21.2K 0.34% 84
2020
Q2 		$657K Buy
1,053
+60
+6% +$34.1K 0.39% 77
2020
Q1 		$485K Buy
993
+353
+55% +$146K 0.33% 82
2019
Q4 		$240K Buy
+640
New +$215K 0.09% 106

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Delta Financial Advisors's REGN Position: Q1 2026 in Review

Delta Financial Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 0.62% in Q1 2026, selling an estimated $6.89K and leaving 1,444 shares worth $1.12M. The position accounts for 0.29% of the portfolio, ranked #88.

Delta Financial Advisors first reported a position in REGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.47M in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Delta Financial Advisors held 1,444 shares of Regeneron Pharmaceuticals worth $1.12M as of Q1 2026.
  • Delta Financial Advisors sold 9 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $6.89K.
  • Regeneron Pharmaceuticals made up 0.29% of Delta Financial Advisors's portfolio in Q1 2026, its #88 holding.
  • Delta Financial Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 26 quarters since.
  • Delta Financial Advisors's Regeneron Pharmaceuticals position peaked at $1.47M in Q2 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Delta Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.